Press Release

Mol Ther 2017 Nov 1

Borel F, et al. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency. Mol Ther. 2017 Nov 1;25(11):2477-2489. Epub 2017 Sep 25.